As reported by The Wall Street Journal, The New
York Times, and other news outlets, Paul, Weiss client Edwards
Lifesciences Corporation and Medtronic, Inc. have reached a global
settlement that resolves all outstanding patent disputes between
the parties. The settlement, which is valued in excess of $1
billion, provides Edwards with a one-time payment of $750 million,
followed by ongoing royalty payments until April 2022 that will
range from $40 million to about $60 million annually.